2026 Alzheimer’s Update
For more than a century Alzheimer’s disease has been thought to be incurable. But a recent study published in the New England Journal of Medicine (NEJM), and reported on by…
Continue Reading
2026 Alzheimer’s Update
UAE Launches First Genomics-Led Trial Aimed at Preventing Alzheimer’s Disease
As reported on PharmaTimes, the United Arab Emirates has taken a significant step toward preventive neurology with the initiation of its first clinical trial guided by population-scale genomics. Spearheaded by…
Continue Reading
UAE Launches First Genomics-Led Trial Aimed at Preventing Alzheimer’s Disease
Possible Mechanism Linking Amyloid and Tau Offers New Direction for Alzheimer’s Therapy
As reported on Scientific American, a growing body of research suggests that Alzheimer’s disease progression is driven by a complex interplay between beta-amyloid plaques and tau neurofibrillary tangles. While both…
Continue Reading
Possible Mechanism Linking Amyloid and Tau Offers New Direction for Alzheimer’s Therapy
New Study Reports How Individual Areas of the Brain Age
A pivotal study recently published in the journal Gero Science has revealed new insights into how individual brain regions age and why some are more severely disrupted by Alzheimer's disease…
Continue Reading
New Study Reports How Individual Areas of the Brain Age
The Weight of Prevention: How Obesity and Hypertension Directly Trigger Dementia
A groundbreaking genetic study published in The Journal of Clinical Endocrinology & Metabolism and reported by ScienceDaily.com has revealed that obesity and high blood pressure don't simply increase dementia risk,…
Continue Reading
The Weight of Prevention: How Obesity and Hypertension Directly Trigger Dementia
Coya Therapeutics Advances Novel Immunotherapy into Clinical Development for Frontotemporal Dementia
Coya Therapeutics has achieved an important regulatory milestone with U.S. FDA acceptance of an Investigational New Drug (IND) application for COYA 302, marking the advancement of a promising new treatment…
Continue Reading
Coya Therapeutics Advances Novel Immunotherapy into Clinical Development for Frontotemporal Dementia
Unlocking the Future: Sleep Disorder Biomarkers Predict Parkinson’s and Dementia
In a groundbreaking international effort led by Dr. Shady Rahayel of Université de Montréal and reported by MSN.com, researchers have discovered new ways to predict which individuals with isolated REM…
Continue Reading
Unlocking the Future: Sleep Disorder Biomarkers Predict Parkinson’s and Dementia
Study Links Age to Increased Alzheimer’s-Related Brain Changes in Parkinson’s Patients Without Dementia
A new study published in Aging-US reveals that Parkinson’s disease (PD) patients diagnosed in their 80s are significantly more likely to exhibit amyloid-beta buildup, which is an early marker of…
Continue Reading
Study Links Age to Increased Alzheimer’s-Related Brain Changes in Parkinson’s Patients Without Dementia
Denmark Researchers Have Created a Light-Based Technology That Improves Cognitive Function for Alzheimer’s Patients
Researchers at UC Berkeley, DTU, and OptoCeutics in Denmark have created a non-medical light-based technology that improved cognitive function for Alzheimer’s patients who have participated in previous clinical trials. The…
Continue Reading
Denmark Researchers Have Created a Light-Based Technology That Improves Cognitive Function for Alzheimer’s Patients
A Nicotine Patch to Deter Dementia?
Humans have been using tobacco as a drug for more than 12,000 years. It wasn't until the early-20th century that the link between tobacco and lung cancer (and other health problems)…
Continue Reading
A Nicotine Patch to Deter Dementia?
source: pixabay.com
Study of the Week: Brain Acidity Linked to a Wide Range of Neurological Diseases
Welcome to Study of the Week from Patient Worthy. In this segment, we select a study we posted about from the previous week that we think is of particular interest…
Continue Reading
Study of the Week: Brain Acidity Linked to a Wide Range of Neurological Diseases
PublicDomainPictures / Pixabay
Using Fruit Flies, Researchers Find Potential Genetic Link to Alzheimer’s
Editor's Note: We believe that patients are a key part of developing and leading the conversation in disease communities. Patient Worthy sometimes partners with reputable agencies that wish to speak…
Continue Reading
Using Fruit Flies, Researchers Find Potential Genetic Link to Alzheimer’s
geralt / Pixabay
Could Deep Brain Stimulation Reduce Alzheimer’s Disease Symptoms?
Editor's Note: We believe that patients are a key part of developing and leading the conversation in disease communities. Patient Worthy sometimes partners with reputable agencies that wish to speak…
Continue Reading
Could Deep Brain Stimulation Reduce Alzheimer’s Disease Symptoms?
GDJ / Pixabay
Man Runs More Than 2,000 Miles to Raise Funds and Awareness for Lewy Body Dementia
Growing up, Jack Witzig saw how his father inspired others. His dad Don was a cross country and track coach at two different high schools. He motivated his students to…
Continue Reading
Man Runs More Than 2,000 Miles to Raise Funds and Awareness for Lewy Body Dementia
source: pixabay.com
Leqembi (Lecanemab) Now Approved for Alzheimer’s Disease
As recently reported by Forbes, the U.S. Food and Drug Administration (FDA) approved Leqembi (lecanemab) for Alzheimer’s disease earlier this week. Leqembi is a humanized monoclonal antibody that targets…
Continue Reading
Leqembi (Lecanemab) Now Approved for Alzheimer’s Disease
source: pixabay.com
Raising Creutzfeldt-Jakob Disease Awareness: Jay and Carol’s Story
We all dream about finding the absolute love of our life: the person that makes us feel warm and supported, the one we can't imagine our world without. For…
Continue Reading
Raising Creutzfeldt-Jakob Disease Awareness: Jay and Carol’s Story
source: pixabay.com
Alzheimer’s Disease: An Influential 2006 Study Containing False Images Leads Scientists To Reverse Previous Theories
The failure rate of drug development for Alzheimer’s is 99 percent according to a recent study. Since 1984 scientists have concentrated on developing treatments to prevent the formation of…
Continue Reading
Alzheimer’s Disease: An Influential 2006 Study Containing False Images Leads Scientists To Reverse Previous Theories
GDJ / Pixabay
Hepatic Encephalopathy: Is Dementia a Common Misdiagnosis?
In the medical world, it’s no secret that misdiagnoses happen. But these misdiagnoses can be costly; patients may miss out on earlier treatment and prevention, and misdiagnosis may correlate with…
Continue Reading
Hepatic Encephalopathy: Is Dementia a Common Misdiagnosis?
source: pixabay.com
Intranasal Oxytocin Derivative Could Reduce Alzheimer’s Cognitive Impairment
Oxytocin has been deemed the "love drug" or "love hormone." This hormone, which controls aspects of behavior and reproduction, is often released when we're in love or in physical…
Continue Reading
Intranasal Oxytocin Derivative Could Reduce Alzheimer’s Cognitive Impairment
https://unsplash.com/photos/w7ZyuGYNpRQ
Could Machine Learning Better Diagnose Alzheimer’s Disease?
Pursuing an Alzheimer’s disease diagnosis can not only be costly, but time-consuming. It may take numerous neuropsychological examinations, alongside other testing and analysis, to confirm this diagnosis. The issue is…
Continue Reading
Could Machine Learning Better Diagnose Alzheimer’s Disease?
Rheumatoid arthritis. Source: James Heilman, MD / CC BY-SA (https://creativecommons.org/licenses/by-sa/3.0)
TNF Inhibitors Do Not Increase Dementia Risk in Patients with RA
In the past, certain research has suggested a relationship between the use of therapies like TNF inhibitors, tocilizumab, and tofacitinib, and a heightened risk of Alzheimer’s disease (AD) or dementia.…
Continue Reading
TNF Inhibitors Do Not Increase Dementia Risk in Patients with RA
source: pixabay.com
Donanemab for AD Granted Breakthrough Therapy Status
Breakthrough Therapy designation is granted by the FDA as a way to accelerate drug development and review. In particular, the designation is granted to drugs or biologics for serious conditions,…
Continue Reading
Donanemab for AD Granted Breakthrough Therapy Status
qimono / Pixabay
Antipsychotic Use Falls in Patients with PD
In the past, antipsychotics were recommended as a potential treatment for patients with Parkinson's disease (PD). This is because, in later stages of PD, patients may experience Parkinson's psychosis, which…
Continue Reading
Antipsychotic Use Falls in Patients with PD
Source: Pixabay
Hemochromatosis Gene Mutations Increase Male Dementia Risk
Is it possible for certain gene mutations, which cause a specific condition, to also raise the risk of developing another condition? Well, says HealthDay, the answer might be yes. In a…
Continue Reading
Hemochromatosis Gene Mutations Increase Male Dementia Risk
source: pixabay.com
Study Shows Glaucoma and Other Eye Conditions May be Linked to Alzheimer’s Disease
Researchers have uncovered that there is a link between Alzheimer's disease and three eye conditions- glaucoma, diabetic retinopathy, and macular degeneration (age-related). This could mean that there may be another…
Continue Reading
Study Shows Glaucoma and Other Eye Conditions May be Linked to Alzheimer’s Disease
